{"id":"W2604078270","doi":"10.1200/jco.2006.24.18_suppl.5017","title":"Angiogenesis pathway gene polymorphisms associated with clinical outcome in recurrent ovarian cancer treated with low dose cyclophosphamide and bevacizumab: A California Consortium Trial","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Medicine; Internal medicine; Ovarian cancer; Angiogenesis; Oncology; Vascular endothelial growth factor; Chemotherapy; Lung cancer; Gastroenterology; Cancer; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009829444,0.0004086036,0.0006908459,0.0001823661,0.0003540637,0.0005356648,0.0004122061,0.0006785299,0.00205588],"category_scores_gemma":[0.001075065,0.0002450543,0.0005215157,0.0004252604,0.0004451376,0.0001705874,0.000258688,0.0007319406,0.0002329117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005827222,"about_ca_system_score_gemma":0.001062916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00488727,"about_ca_topic_score_gemma":0.007584879,"domain_scores_codex":[0.9995697,0.0002243154,0.00002189765,0.00009710563,0.0000426511,0.0000442257],"domain_scores_gemma":[0.9991135,0.0001878906,0.0002139029,0.00007317732,0.0000611872,0.000350298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6953437,0.00884977,0.2184917,0.0004410335,0.002828084,0.0002784287,0.0002445863,0.001260603,0.01898281,0.0002414573,0.004217699,0.04882025],"study_design_scores_gemma":[0.3381523,0.0884019,0.5601878,0.0001148383,0.003554935,0.0004410884,0.000138219,0.001461145,0.00159497,0.0001651708,0.005731313,0.00005644424],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978938,0.000648966,0.00005483949,0.0002095161,0.00002227689,0.0001547767,0.0002813087,0.000009495745,0.0007251081],"genre_scores_gemma":[0.9972436,0.0003613225,0.0002007736,0.0002136028,0.00006561247,0.0001932339,0.0009011153,0.00000521534,0.0008155317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00488727,"threshold_uncertainty_score":0.009717643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0429587053098725,"score_gpt":0.3660125625494076,"score_spread":0.3230538572395351,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}